cancer-research
41 stories related to this topic, newest first.
The IndependentOxford University and Moderna to begin cancer vaccine trials this summer
A vaccine developed by Oxford University and Moderna will enter clinical testing this summer in patients with Lynch syndrome. The trial will assess whether the mRNA shot can train the immune system to destroy pre-cancerous cells before tumors form.
zmescience.comJohnson & Johnson to Acquire KRAS Startup Firefly Bio for $1 Billion After Recent Pancreatic Cancer Data Validates Field
The acquisition targets KRAS inhibitors after Revolution Medicines reported nearly doubled survival in metastatic pancreatic cancer less than two months earlier.
The IndependentNew Pancreatic Cancer Drug Doubles Survival Time in Trial
A daily pill extended median survival from 6.5 to 13.5 months for patients with advanced pancreatic cancer in a 500-person study. Separate early trials showed a smart drug shrank tumors in six common cancers, and observational data linked GLP-1 weight-loss drugs to lower cancer r…
The GuardianAustralian Melanoma Researcher Richard Scolyer Dies at 59 After Experimental Glioblastoma Treatment
Professor Richard A Scolyer, joint 2024 Australian of the Year, died on 7 June 2026 after a three-year battle with glioblastoma. He left an open letter urging continued investment in brain cancer research.
Los Angeles TimesCalifornia Researchers Launch $12.5 Million Nationwide Study of Cancer Patterns in Asian Americans
UCSF and partner institutions will track 20,000 participants to examine rising lung and breast cancer rates. The ASPIRE Cohort is the first large-scale longitudinal study focused on this population.
StatPatient Reports Benefit from Revolution Medicines’ Daraxonrasib as Oncologists Applaud Data but Biotech Stocks Fall
Leanna Stokes, diagnosed with metastatic pancreatic cancer in 2023, discussed her experience in a Revolution Medicines clinical trial on a June 4, 2026 podcast. Oncologists gave a standing ovation to data on the company’s drug daraxonrasib presented at last week’s American Societ…
cnbc.comLarge NCI-Funded Phase 3 Trial Tests Probiotic CBM588 With Immunotherapy in Advanced Kidney Cancer
A multicenter study funded by the National Cancer Institute will test whether CBM588 improves outcomes when taken with immunotherapy in nearly 700 people with advanced renal cell carcinoma.
Substrate placeholder — needs reviewSmall Phase-2 Trial Finds 85% of Bladder Cancer Patients Cancer-Free at One Year With Added Immunotherapy
A phase-two study found that adding durvalumab to chemotherapy and radiotherapy kept cancer from returning in 46 of 54 patients. The approach may allow some patients to avoid bladder removal surgery.
Nbc NewsPersonalized mRNA Vaccine Shows Reduced Melanoma Recurrence in Small Phase 2 Trial
A Moderna and Merck experimental vaccine cut melanoma recurrence risk by half in a five-year trial. Results were presented June 1, 2026, at the American Society of Clinical Oncology meeting.
GB NewsCanadian Researcher With Stage Four Cancer Reaches Everest Summit
Dr Shaunna Burke reached the summit at 3 a.m. on May 23 while managing terminal breast cancer and chemotherapy, raising funds for Macmillan Cancer Support.
fortune.comDrug Doubles Survival in Metastatic Pancreatic Cancer Trial
An international trial presented Sunday showed daraxonrasib doubled median survival for patients with metastatic pancreatic cancer compared with standard chemotherapy. France has expanded a personalized screening program to eight additional centers.
Science NewsPill Nearly Doubles Survival Time in Pancreatic Cancer Trial
A once-daily pill nearly doubled average survival for patients with advanced pancreatic cancer in a 500-patient randomized study. Patients on the drug lived 13.2 months on average versus 6.6 months on chemotherapy.
Amivantamab Shows Tumor Response in 43 of 102 Patients With Advanced Head and Neck Cancer
An 11-nation trial of the Johnson & Johnson drug showed tumor shrinkage in more than a third of patients whose disease had returned or spread. Median survival reached 12.5 months after treatment began.
The GuardianAmivantamab Shows Tumor Responses in 43 of 102 Patients with Advanced Head and Neck Cancer
An international trial found the Johnson & Johnson drug shrank or eliminated tumors in 43 of 102 patients whose disease had resisted prior chemotherapy and immunotherapy. Results will be presented Sunday at the American Society of Clinical Oncology meeting in Chicago.
freepressjournal.inLung cancer in never-smokers recognized as distinct disease
Medical researchers now classify lung cancer in people who have never smoked as a separate condition. The classification includes dedicated treatments and prevention approaches.
sixthtone.comPancreatic cancer treatment advance prompts pharmaceutical deal activity
A recent medical advance in pancreatic cancer treatment has led to increased dealmaking among pharmaceutical companies. The development follows years of limited progress in the disease area.
prweb.comStudy Examines How Anti-PD-1 Antibodies Affect Immune Cell Signaling
A new study published in Science Immunology reports that anti-PD-1 antibodies trap PD-1 proteins at nanoscale immune contacts and trigger inhibitory checkpoint signaling. The findings identify potential targets for improving immunotherapy design.
StatMerck-Kelun Drug Reduced Lung Cancer Progression Risk by 65 Percent in Trial
Phase 3 study results showed that a targeted chemotherapy developed by Kelun-Biotech and licensed to Merck reduced tumor progression risk by 65 percent in patients with advanced non-small cell lung cancer. A preliminary survival benefit was observed but requires longer follow-up…
EuronewsStudy Detects Cancer-Causing Viruses in Texas Wastewater Samples
Researchers identified major oncogenic viruses in wastewater from 16 Texas cities. The findings could support future public health monitoring of infection trends.
Fox NewsMerck Drug Sac-TMT Meets Survival Goals in Endometrial Cancer Trial
Merck announced Monday that its investigational drug sacituzumab tirumotecan met primary survival endpoints in a Phase 3 trial for advanced or recurrent endometrial cancer. The TroFuse-005 study compared the drug to physician-chosen chemotherapy in 776 patients.
Science NewsDamaged DNA Travels Between Human Cells via Nanotubes
Researchers observed DNA fragments moving from one human cell to another through tunneling nanotubes after genome damage. The study, published May 19 in Cell, shows the transferred DNA can carry functional genes.
ncbi.nlm.nih.govStudy Shows Heartbeat Limits Tumor Growth in Cardiac Tissue
A Science study reports that the mechanical forces from constant heart contractions alter gene regulation in cancer cells. The research examines how these forces may prevent tumor development in heart tissue.
nbcnews.comStudy Links Grey Hair in Mice to Cellular Process
A new mouse study examined how melanocyte stem cells respond to DNA damage. Researchers found that certain damage types trigger a process leading to grey hair while removing potentially cancerous cells.
Fox NewsSmall University of Rochester Trial Finds Modest Cognitive Benefits From Exercise and Ibuprofen During Chemotherapy
A phase 2 trial of 86 cancer patients undergoing chemotherapy showed that a six-week home exercise program produced the clearest gains in attention and cognitive function. Low-dose ibuprofen alone also yielded greater cognitive improvements than placebo. Researchers cautioned tha…
ncbi.nlm.nih.govAndrogen Loss Accelerates Brain Tumour Growth in Mouse Models
A research paper reports that androgen deprivation via castration speeds intracranial tumour growth in mice with glioblastoma while slowing extracranial tumours. The study links the effect to elevated glucocorticoids, systemic T cell dysfunction and an immunosuppressive tumour mi…
scienceblog.cancerresearchuk.orgCancer Research UK Closes Aberdeen Store as Part of 190-Shop Reduction Plan
Cancer Research UK closed its Aberdeen branch on Rosemount Viaduct on May 8, 2026, as the first wave of 90 permanent store closures scheduled for completion by the end of the month. The charity announced the restructuring programme in October 2025, citing rising costs, declining…
medium.comMachine-Learning Analysis Identifies Nine Conserved Spatial Ecotypes Across Human Tumors
Researchers integrated more than 10 million single-cell and spot-level spatial transcriptomes from diverse human carcinomas and melanomas to define nine spatial ecotypes. Each ecotype shows unique biology, geospatial features and clinical outcome associations, including links to…
link.springer.comMachine Learning Framework Identifies Tumor Microenvironment Ecotypes in Blood Samples
Researchers developed a machine learning approach that identifies nine spatial ecotypes in the tumor microenvironment from over 10 million single-cell and spatial transcriptomes across multiple cancer types. The ecotypes can be detected noninvasively through cell-free DNA methyla…
deadline.comPolish Streamer Łatwogang Raises Over $70 Million for Childhood Cancer in 9-Day Broadcast
Polish streamer Łatwogang completed a 9-day live broadcast that raised more than 250 million złoty, equivalent to about $70 million, for childhood cancer patients. The event, which ended yesterday, set a new world record for charity fundraising during a live stream. @MarioNawfal…
dailyexcelsior.comHeart Beating Inhibits Cancer Growth in Mice, Study in Science Reveals
A new study published today in Science shows that the mechanical beating of the heart prevents cancer cells from proliferating in mouse hearts. Researchers transplanted non-beating hearts and observed rapid cancer growth compared to native beating hearts. This finding may explain…
fortune.comMouse Study Finds Heart's Mechanical Stress May Inhibit Cancer Metastasis
Researchers in Italy published a study in Science suggesting that the heart's constant beating creates a hostile environment for cancer cells. The work, conducted in mice, identified genetic mechanisms and a protein that senses mechanical forces. Experts called the findings hypot…
ecns.cnResearchers Identify GPX4 Inhibitors That Target Senescent Cells in Cancer Models
A study has identified GPX4 inhibitors that selectively kill senescent cells, which accumulate in tumors after chemotherapy. These compounds showed effectiveness in preclinical models of melanoma, prostate, and ovarian cancer. The findings suggest a potential new strategy for can…
ndtv.comMouse Study Finds Heart's Mechanical Stress May Suppress Cancer Growth
Researchers published a study in Science suggesting that the heart's constant beating creates an environment hostile to cancer. The work, conducted in mice, identified genetic mechanisms linked to mechanical forces. Experts called the findings hypothesis-generating and pointed to…
Substrate placeholder — needs reviewRevolution Medicines Presents Strong KRAS Drug Data and Preclinical Compound Insights
Revolution Medicines shared clinical trial success for its pancreatic cancer therapy last week and preclinical data on a new compound yesterday. The company also presented strong results for its KRAS drug at the AACR meeting on April 21, 2026. Additional biotech developments incl…
Opabinia regalis / Wikimedia (CC BY-SA 4.0)Study Reveals EBV Variant and Host Gene Interaction as Key Driver of Nasopharyngeal Carcinoma Risk
Researchers identified a genetic interaction between a high-risk Epstein-Barr virus variant and specific host HLA alleles that significantly elevates nasopharyngeal carcinoma risk in southern China. The findings, published in Nature, highlight a dual-risk subgroup accounting for…
Substrate placeholder — needs reviewSutro Biopharma Presents Preclinical Data on ADC Programs at AACR 2026
Sutro Biopharma announced preclinical data for its antibody drug conjugate programs at the American Association for Cancer Research Annual Meeting 2026. The data covered STRO-004 and other next-generation ADCs, showing antitumor activity in solid tumor models. Initial Phase 1 stu…
Substrate placeholder — needs reviewGiant Cancer Study Evaluates Effectiveness of Off-Label Treatments
A recent study has assessed the effectiveness of off-label cancer treatments, revealing significant findings. The research highlights the potential benefits and risks associated with these therapies.
National Institutes of Health. / Wikimedia (Public domain)Researchers Develop AI Method to Identify Bevacizumab Responders in Advanced Bowel Cancer
Scientists at the Institute of Cancer Research in London and RCSI University of Medicine and Health Sciences in Dublin have developed an AI tool to predict which patients with advanced bowel cancer will benefit from bevacizumab. The method, published in Scientific Reports, analyz…
Substrate placeholder — needs reviewGSK Presents Early-Stage Data on Experimental Cancer Drug and Plans Five Phase 3 Trials
GSK presented data from an early-stage clinical trial of an experimental cancer drug over the weekend. The company stated that the results support advancing the drug to five Phase 3 trials this year. This development follows initial testing to evaluate the drug's safety and preli…
Substrate placeholder — needs reviewLung Cancer Rates Rise Among Nonsmoking Asian American and Latina Women Amid Limited Screening Access
A 2023 study reported that lung cancer rates among nonsmoking Asian American women increased by 2 percent annually from 2007 to 2018, while rates decreased in other groups. Federal screening guidelines limit coverage for low-dose CT scans to individuals aged 50 to 80 with signifi…
Substrate placeholder — needs reviewRecent Health News Highlights Breakthrough in Duchenne Treatment and Insulin Price Cap
A new therapy shows promise for Duchenne muscular dystrophy patients. Insulin prices are capped at $35 for many users. Additional evidence supports over-the-counter availability of abortion medications.